Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
Public ClinicalTrials.gov record NCT02456740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.
Study identification
- NCT ID
- NCT02456740
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 955 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 16, 2015
- Primary completion
- Sep 4, 2016
- Completion
- Jun 18, 2017
- Last update posted
- Oct 11, 2022
2015 – 2017
United States locations
- U.S. sites
- 59
- U.S. states
- 26
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85023 | — |
| Research Site | Anaheim | California | 92801 | — |
| Research Site | Encino | California | 91316 | — |
| Research Site | Irvine | California | 92618 | — |
| Research Site | Los Alamitos | California | 90720 | — |
| Research Site | Newport Beach | California | 92660 | — |
| Research Site | Rancho Mirage | California | 92270 | — |
| Research Site | Redlands | California | 92374 | — |
| Research Site | Sherman Oaks | California | 91403 | — |
| Research Site | Simi Valley | California | 93065 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Boulder | Colorado | 80301 | — |
| Research Site | East Hartford | Connecticut | 06118 | — |
| Research Site | Stamford | Connecticut | 06905 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Bradenton | Florida | 34205 | — |
| Research Site | Jacksonville | Florida | 32256 | — |
| Research Site | Leesburg | Florida | 34748 | — |
| Research Site | Miami | Florida | 33135 | — |
| Research Site | Ocala | Florida | 34471 | — |
| Research Site | Orlando | Florida | 32801 | — |
| Research Site | Sunrise | Florida | 33351 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Atlanta | Georgia | 30328 | — |
| Research Site | Boise | Idaho | 83704 | — |
| Research Site | Evansville | Indiana | 47714 | — |
| Research Site | Des Moines | Iowa | 50309 | — |
| Research Site | Newton | Kansas | 67114 | — |
| Research Site | Wichita | Kansas | 67207 | — |
| Research Site | Edgewood | Kentucky | 41017 | — |
| Research Site | Metairie | Louisiana | 70006 | — |
| Research Site | New Orleans | Louisiana | 70119 | — |
| Research Site | New Bedford | Massachusetts | 02740 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Plymouth | Minnesota | 55441 | — |
| Research Site | Kansas City | Missouri | 64114 | — |
| Research Site | Springfield | Missouri | 65807 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Amherst | New York | 14226 | — |
| Research Site | Plainview | New York | 11803 | — |
| Research Site | Rochester | New York | 14609 | — |
| Research Site | Durham | North Carolina | 27713 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | Cleveland | Ohio | 44122 | — |
| Research Site | Cleveland | Ohio | 44195 | — |
| Research Site | Willoughby Hills | Ohio | 44094 | — |
| Research Site | Portland | Oregon | 97210 | — |
| Research Site | Philadelphia | Pennsylvania | 19107 | — |
| Research Site | Cumberland | Rhode Island | 02864 | — |
| Research Site | Port Royal | South Carolina | 29935 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Bedford | Texas | 76022 | — |
| Research Site | Irving | Texas | 75039 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Salt Lake City | Utah | 84109 | — |
| Research Site | West Jordan | Utah | 84088 | — |
| Research Site | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02456740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02456740 live on ClinicalTrials.gov.